Rachel Nuwer is a freelance science journalist who contributes to outlets such as the New York Times, Scientific American and New Scientist. She writes news articles for Spectrum. She lives in Brooklyn.
Rachel Nuwer
Contributing Writer
Spectrum
From this contributor
Lisa Croen: Autism’s first dedicated epidemiologist
Inspired by watching her autistic nephew grow up, Croen has also been an advocate for bolstering research and services for autistic adults.
Lisa Croen: Autism’s first dedicated epidemiologist
By
Rachel Nuwer
28 March 2022 | 9 min read
Finding strengths in autism
Autism comprises a set of difficulties, but growing evidence suggests that certain abilities also define the condition.
Meet the autistic scientists redefining autism research
Growing ranks of researchers on the spectrum are overcoming barriers — from neurotypical bias to sensory sensitivities — to shape autism science.
Meet the autistic scientists redefining autism research
By
Rachel Nuwer
10 June 2020 | 18 min read
Growing old with autism
For many autistic adults, the golden years are tarnished by poor health, poverty and, in some cases, homelessness. Their plight reveals huge gaps in care.
Mouse study links gene to some autism symptoms
Mice missing a gene called PTCHD1 in a deep-seated brain structure have autism-like symptoms that ease with treatment.
Explore more from The Transmitter
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
By
Claudia López Lloreda
2 October 2025 | 6 min read
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
By
Calli McMurray
2 October 2025 | 10 min read
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
By
Brendan Borrell
1 October 2025 | 11 min read